Association of a PDCD1 Polymorphism With Sympathetic Ophthalmia in Han Chinese

被引:12
作者
Deng, Jing [1 ,2 ]
Hu, Jiayue [1 ,2 ]
Tan, Handan [1 ,2 ]
Su, Guannan [1 ,2 ]
Cao, Qingfeng [1 ,2 ]
Huang, Xinyue [1 ,2 ]
Kijlstra, Aize [3 ]
Yang, Peizeng [1 ,2 ]
机构
[1] Chongqing Med Univ, Chongqing Key Lab Ophthalmol, Affiliated Hosp 1, Chongqing, Peoples R China
[2] Chongqing Eye Inst, Chongqing, Peoples R China
[3] Univ Eye Clin Maastricht, Maastricht, Limburg, Netherlands
关键词
PDCD1; sympathetic ophthalmia; Vogt-Koyanagi-Harada disease; polymorphism; KOYANAGI-HARADA-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BEHCETS-DISEASE; GENE POLYMORPHISMS; VKH SYNDROME; RHEUMATOID-ARTHRITIS; PD-1; GENE; POPULATION; RISK; SUSCEPTIBILITY;
D O I
10.1167/iovs.17-22195
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Several studies have shown that sympathetic ophthalmia (SO) and Vogt-Koyanagi-Harada (VKH) disease possess many similarities concerning their clinical manifestations. The aim of this study was to investigate whether single nucleotide polymorphisms that have been shown to be associated with VKH disease in earlier studies may also be associated with SO. METHODS. There were 114 SO patients and 1230 healthy controls included in a case-control study, whereby 24 VKH-related single nucleotide polymorphisms (SNPs) were tested. Genotyping was performed using the MassARRAY platform and iPLEX Gold Assay. RESULTS. The results showed a significantly lower frequency of the PDCD1/rs2227981 GG genotype in SO (Pc = 7.85 x 10(-3), OR = 0.471). However, no apparent increase in the GA and AA genotype frequency was detected. Moreover, a significant decrease in the G allele frequency of PDCD1/rs2227981 was detected in SO (Pc = 5.08 x 10(-3), OR = 0.56). CONCLUSIONS. This study shows that only PDCD1/rs2227981 contributes to the genetic susceptibility of SO, and that the other 23 susceptibility loci of VKH disease are probably not involved in the pathogenesis of this disease.
引用
收藏
页码:4218 / 4222
页数:5
相关论文
共 43 条
[1]   Expression of chemokines and gelatinase B in sympathetic ophthalmia [J].
Abu El-Asrar, A. M. ;
Struyf, S. ;
Van den Broeck, C. ;
Van Damme, J. ;
Opdenakker, G. ;
Geboes, K. ;
Kestelyn, P. .
EYE, 2007, 21 (05) :649-657
[2]   Sympathetic Ophthalmia [J].
Chang, Grace C. ;
Young, Lucy H. .
SEMINARS IN OPHTHALMOLOGY, 2011, 26 (4-5) :316-320
[3]   Elevated Serum Osteopontin Levels and Genetic Polymorphisms of Osteopontin Are Associated with Vogt-Koyanagi-Harada Disease [J].
Chu, Mingliang ;
Yang, Peizeng ;
Hu, Ranran ;
Hou, Shengping ;
Li, Fuzhen ;
Chen, Yuanyuan ;
Kijlstra, Aize .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (10) :7084-7089
[4]   Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population [J].
Chua, Kek Heng ;
Lian, Lay Hoong ;
Sim, Xiu Jia ;
Cheah, Tien Eang ;
Lau, Tze Pheng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (05) :9794-9803
[5]  
DAVIS JL, 1990, OPHTHALMOLOGY, V97, P1137
[6]   CELLULAR IMMUNE-RESPONSES OF PATIENTS WITH UVEITIS TO RETINAL ANTIGENS AND THEIR FRAGMENTS [J].
DESMET, MD ;
YAMAMOTO, JH ;
MOCHIZUKI, M ;
GERY, I ;
SINGH, VK ;
SHINOHARA, T ;
WIGGERT, B ;
CHADER, GJ ;
NUSSENBLATT, RB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 110 (02) :135-142
[7]   Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome [J].
Du, Liping ;
Yang, Peizeng ;
Hou, Shengping ;
Lin, Xiaomin ;
Zhou, Hongyan ;
Huang, Xiangkun ;
Wang, Li ;
Kijlstra, Aize .
CLINICAL IMMUNOLOGY, 2008, 127 (01) :43-48
[8]   Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment [J].
Du, Liping ;
Kijlstra, Aize ;
Yang, Peizeng .
PROGRESS IN RETINAL AND EYE RESEARCH, 2016, 52 :84-111
[9]  
Furusato E, 2011, HISTOL HISTOPATHOL, V26, P1145, DOI 10.14670/HH-26.1145
[10]   Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk [J].
Gao, Jie ;
Gai, Nan ;
Wang, Li ;
Liu, Kang ;
Liu, Xing-Han ;
Wei, Lin-Ting ;
Tian, Tian ;
Li, Shan-Li ;
Zheng, Yi ;
Deng, Yu-Jiao ;
Dai, Zhi-Jun ;
Fu, Rong-Guo .
ONCOTARGET, 2017, 8 (22) :36885-36897